Education
About Us
Working with TipRanks
Follow Us
CLEO Diagnostics Ltd (AU:COV)
ASX:COV
COV Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.16 - AU$0.62
Previous CloseN/A
Volume276.00
Average Volume (3M)150.99K
Market Cap
N/A
Enterprise ValueAU$34.32M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.01
Next Earnings
Aug 27, 2025Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding128,500,000
10 Day Avg. Volume206,302
30 Day Avg. Volume150,994
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
CLEO Diagnostics Ltd News
PremiumCompany Announcements
Cleo Diagnostics Advances Ovarian Cancer Test Towards Commercialization
PremiumCompany Announcements
Cleo Diagnostics Advances Ovarian Cancer Test Development
PremiumCompany Announcements
Cleo Diagnostics Reports Reduced Losses and Advances Clinical Trials
PremiumCompany Announcements
Cleo Diagnostics Advances Ovarian Cancer Test with U.S. and Australian Trials
PremiumCompany Announcements
Cleo Diagnostics Expands Ovarian Cancer Trial with Siles HealthPremiumCompany Announcements
Cleo Diagnostics Announces Successful AGM Resolutions---
COV FAQ
What was CLEO Diagnostics Ltd’s price range in the past 12 months?
CLEO Diagnostics Ltd lowest share price was AU$0.16 and its highest was AU$0.62 in the past 12 months.
What is CLEO Diagnostics Ltd’s market cap?
Currently, no data Available
When is CLEO Diagnostics Ltd’s upcoming earnings report date?
CLEO Diagnostics Ltd’s upcoming earnings report date is Aug 27, 2025 which is in 127 days.
How were CLEO Diagnostics Ltd’s earnings last quarter?
CLEO Diagnostics Ltd released its earnings results on Feb 27, 2025. The company reported -AU$0.015 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.015.
Is CLEO Diagnostics Ltd overvalued?
According to Wall Street analysts CLEO Diagnostics Ltd’s price is currently Overvalued.
Does CLEO Diagnostics Ltd pay dividends?
CLEO Diagnostics Ltd does not currently pay dividends.
What is CLEO Diagnostics Ltd’s EPS estimate?
CLEO Diagnostics Ltd’s EPS estimate is 0.
How many shares outstanding does CLEO Diagnostics Ltd have?
CLEO Diagnostics Ltd has 128,500,000 shares outstanding.
What happened to CLEO Diagnostics Ltd’s price movement after its last earnings report?
CLEO Diagnostics Ltd reported an EPS of -AU$0.015 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.407%.
Which hedge fund is a major shareholder of CLEO Diagnostics Ltd?
Currently, no hedge funds are holding shares in AU:COV
---
CLEO Diagnostics Ltd Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:COV Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
87.50%
12-Months-Change
Fundamentals
Return on Equity
-34.46%
Trailing 12-Months
Asset Growth
-26.53%
Trailing 12-Months
Technical Analysis
CardieX Limited
―
BrainChip Holdings
―
Cynata Therapeutics Limited
―
Imugene Limited
―
Race Oncology Ltd.
―
---